Pfizer shares surged over 9% in early trade after the company reported a robust year-on-year performance for the third quarter, driven by strong revenue growth and a sharp improvement in operating profitability. The stock witnessed healthy buying interest as investors reacted positively to higher margins and steady profit growth.
On a consolidated year-on-year basis, Pfizer reported revenue of ₹645.03 crore for Q3, marking a growth of 19.89% compared with ₹537.99 crore in the corresponding quarter last year.
Operating performance stood out during the quarter. EBITDA rose sharply by 56.3% to ₹228.19 crore from ₹145.99 crore in the year-ago period. This translated into a significant margin expansion, with EBITDA margin improving by 824 basis points to 35.37%, compared with 27.13% last year.
Net profit for the quarter increased by 11.15% to ₹141.84 crore, compared with ₹127.6 crore in the same period last year, supporting the overall positive earnings momentum despite a comparatively moderate growth at the bottom line.
Pfizer share price performance
As of 9:40 AM IST, Pfizer shares were trading sharply higher, reflecting strong investor sentiment following the Q3 results. The stock opened at ₹4,930.90, compared with the previous close of ₹4,764.10. During the session, the share price touched a low of ₹4,899.00 and surged to an intraday high of ₹5,257.00.
On a longer-term basis, the stock remains well above its 52-week low of ₹3,701.00, while still below its 52-week high of ₹5,993.00.